Cas:83877-91-2 (Z)-4-ethoxy-4-oxobut-2-en-2-olate,2-methylpropan-1-olate,titanium(4+) manufacturer & supplier

Chemical Name:(Z)-4-ethoxy-4-oxobut-2-en-2-olate,2-methylpropan-1-olate,titanium(4+)

CAS.NO:83877-91-2

Synonyms:Bis(ethyl acetoacetato-O1′,O3)bis(2-methylpropan-1-olato)titanium;Titanium,bis(ethyl 3-oxobutanoato-kappaO1′,kappaO3)bis(2-methyl-1-propanolato);Titanium,bis(ethyl 3-oxobutanoato-O1′,O3)bis(2-methyl-1-propanolato)

Molecular Formula:C₂₀H₃₆O₈Ti

Molecular Weight:452.36200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:225.4ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:89.52000

Exact Mass:452.18900

LogP:4.11500

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1993

Packing Group:

Contact us for information like Bis(ethyl acetoacetato-O1′,O3)bis(2-methylpropan-1-olato)titanium chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Titanium,bis(ethyl 3-oxobutanoato-O1′,O3)bis(2-methyl-1-propanolato) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis(ethyl acetoacetato-O1′,O3)bis(2-methylpropan-1-olato)titanium Use and application,Titanium,bis(ethyl 3-oxobutanoato-kappaO1′,kappaO3)bis(2-methyl-1-propanolato) technical grade,usp/ep/jp grade.

Related News: Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. (Z)-4-ethoxy-4-oxobut-2-en-2-olate,2-methylpropan-1-olate,titanium(4+) manufacturer With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs. (Z)-4-ethoxy-4-oxobut-2-en-2-olate,2-methylpropan-1-olate,titanium(4+) supplier If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. (Z)-4-ethoxy-4-oxobut-2-en-2-olate,2-methylpropan-1-olate,titanium(4+) vendor If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. (Z)-4-ethoxy-4-oxobut-2-en-2-olate,2-methylpropan-1-olate,titanium(4+) factory Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.